Product Information

RENVELA 2.4 GM POWDER PACKET is a brand product labeled by Genzyme Corporation, priced at $17.1932 per EA under NDC 58468013102. Its NADAC has been published 390 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the SEVELAMER CARBONATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

RENVELA 2.4 GM POWDER PACKET

SEVELAMER CARBONATE
$17.1932per EA
High Outlier

Strength

2400 mg/1

NDC

58468013102

Classification

Brand

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Last Updated

5/21/2025

Active Ingredients

SEVELAMER CARBONATE

Approval Type

New Drug (NDA)

FDA Application

NDA022318

On Market Since

8/12/2009

Pharmacological Classes

Phosphate Binder
Phosphate Chelating Activity

Price Statistics

The NADAC for RENVELA 2.4 GM POWDER PACKET has been published 390 times since Nov 28, 2013, and over the history we have for it it has risen 84.4%. The table below summarizes its recorded NADAC range and movement.

Current price$17.1932 per EA
All-time high$17.1990 (May 14, 2025)
All-time low$9.3253 (Nov 28, 2013)
52-week high$17.1932
52-week low$17.1932
Median price$16.3372
Average price$15.3863
Largest weekly change+9.9% (Nov 19, 2014)
Weeks tracked390
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+5.6%

5Y

+5.6%

All

+84.4%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 93%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of RENVELA 2.4 GM POWDER PACKET?

The current National Average Drug Acquisition Cost (NADAC) for RENVELA 2.4 GM POWDER PACKET, manufactured by Genzyme Corporation, is $17.1932 per EA (NDC 58468013102), effective May 13, 2026.

How has the price of RENVELA 2.4 GM POWDER PACKET changed over time?

Over the history we have for it, the NADAC for RENVELA 2.4 GM POWDER PACKET has risen 84.4%. It has been tracked across 390 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for RENVELA 2.4 GM POWDER PACKET?

Since Nov 28, 2013, the NADAC for RENVELA 2.4 GM POWDER PACKET has ranged from a low of $9.3253 (Nov 28, 2013) to a high of $17.1990 (May 14, 2025), with a median of $16.3372 per EA.

Are there cheaper alternatives to RENVELA 2.4 GM POWDER PACKET?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, SEVELAMER 2.4 GM POWDER PACKET, is $1.1337 per EA — about 93% below RENVELA 2.4 GM POWDER PACKET.

Who manufactures RENVELA 2.4 GM POWDER PACKET?

RENVELA 2.4 GM POWDER PACKET (NDC 58468013102) is labeled by Genzyme Corporation, and CMS classifies it as a brand product.